New qPCR Multiplexing Probes Aim to Reduce Turnaround Times and Streamline Ordering
The probes allow up to 5-plex multiplexing and are paired with a modernized online tool for ordering qPCR components.
The probes allow up to 5-plex multiplexing and are paired with a modernized online tool for ordering qPCR components.
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
Study shows Foresight CLARITY demonstrated 68% pre-operative and 38% post-operative MRD detection rates in stage I lung cancer patients.
The new platform offers three-tiered approach to help laboratories at different stages of data maturity extract actionable insights from operational data.
Seattle startup will use funding to develop urine-based tuberculosis test using engineered NovoBodies technology for low-resource settings.